FDA grants AI algorithm for heart failure Breakthrough Device designation
The free newsletter covering the top headlines in AI
The free newsletter covering the top headlines in AI
Contact: Julie Boyland, jboyland@acc.org, During the American College of Cardiology’s Annual Scientific Session (ACC.25), 40 domestic teams and four international teams faced off in the…
Gestational diabetes and hypertensive disorders of pregnancy may be markers for rather than mediators of risk for future CVD, according to new research.
Swedish study suggests more MACE with delayed addition of ezetimibe to statins after heart attack
Contact: Olivia Walther, owalther@acc.org, Complications during pregnancy (or adverse pregnancy outcomes), like gestational diabetes and newly developed high blood pressure, act as nature’s stress test…
First-gen device tied to ‘acceptable’ clinical outcomes and low pacemaker rate at 1 year
Contact: Olivia Walther, owalther@acc.org, Cardiac deaths increase significantly during compound heatwaves — heatwaves where temperatures are elevated both during the day and overnight — according…
ACC President Christopher Kramer, MD, testified before a Congressional subcommittee to ask for federal funding to support a new law aimed at reducing sudden cardiac…
ACC President Christopher Kramer, MD, testified before a Congressional subcommittee to ask for federal funding to support a new law aimed at reducing sudden cardiac…
AI outperformed clinicians and almost matched hs-TnT testing, but one expert questioned if this is where it’s needed most.
Data from the REVERSE-IT trial provide vital insight into the efficacy and safety of bentracimab as an FDA decision looms on the horizon.